Novel Synthetic Opioids: The Pathologist’s Point of View

@inproceedings{Frisoni2018NovelSO,
  title={Novel Synthetic Opioids: The Pathologist’s Point of View},
  author={Paolo Frisoni and Erica Bacchio and Sabrine Bilel and Anna Talarico and Rosa Maria Gaudio and M. Teresita de Barbieri and Margherita Neri and Matteo Marti},
  booktitle={Brain sciences},
  year={2018}
}
BACKGROUND New Psychoactive Substances (NPS) constitute a broad range of hundreds of natural and synthetic drugs, including synthetic opioids, synthetic cannabinoids, synthetic cathinones, and other NPS classes, which were not controlled from 1961 to 1971 by the United Nations drug control conventions. Among these, synthetic opioids represent a major threat to public health. METHODS A literature search was carried out using public databases (such as PubMed, Google Scholar, and Scopus) to… CONTINUE READING
5
Twitter Mentions

Similar Papers

Tables and Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 125 REFERENCES

A review: Fentanyl and non-pharmaceutical fentanyls.

  • Drug and alcohol dependence
  • 2017
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Fentanyl novel derivative-related deaths.

VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Two fatalities associated with synthetic opioids: AH-7921 and MT-45.

  • Forensic science international
  • 2017
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

A fatality involving AH-7921.

  • Journal of analytical toxicology
  • 2014
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL